Roche Deals With Huge Gantenerumab Curiosity At H1 Update

Anti-Amyloid Beta Therapy Is In Phase III For Alzheimer's

 
• By Sten Stovall
Swiss Pharma Said Filing Decision Must Await GRADUATE Data Next Year • Source: Alamy

More from Earnings

More from Business